As you know, the Consolidated Appropriations Act (CAA) requires insurance companies to submit information about prescription drugs and health care spending in the form of an RXDC report. EmblemHealth is obligated to reporting on every employer that was covered in 2023.
The 2023 reporting is due June 1, 2024. To collect the data, EmblemHealth has emailed a survey link to your fully insured and self-funded groups for them to provide the requested information. Should an ASO customer want to submit the Prescription Drug and Health care Spending report on their own, they should contact their Senior Account Executive for exclusion.
Responses are due by Mar 3, 2024
Visit EmblemHealth's CAA page to learn how Emblem is handling all reporting related to Transparency in Coverage requirements.